COVID-19 Resource Community Blog

Amidst the chaos of the COVID-19 pandemic, caring for patients through the BMT process has become increasingly arduous. Not only are patients feeling increased fear, stress, and anxiety as they move through challenging treatment regimens, but healthcare providers are experiencing increasing demands both at home and at work... Click here to read more.

These past few weeks have felt endless. But now it appears there might be a small light at the end of the tunnel. Many cities and states are beginning to ponder their plans for reopening—and a few have slowly begun lifting their restrictions... Click here to read more.

ASTCT, along with 20 other organizations and institutions, signed a letter to the Department of Health and Human Services this week, urging officials to ensure the on-time delivery of absolutely essential, life-saving therapies to those most in need during this unprecedented worldwide crisis.... Click here to read more.

ASTCT, along with 20 other organizations and institutions, signed a letter to the Department of Health and Human Services this week, urging officials to ensure the on-time delivery of absolutely essential, life-saving therapies to those most in need during this unprecedented worldwide crisis... Click here to read more.

The U.S. Food and Drug Administration (FDA) announced on March 24th that it will allow physicians to use convalescent plasma collected from recovered COVID-19 patients in patients with serious or immediately life-threatening COVID-19 infections. This will be through the process of single patient emergency Investigational New Drug Applications (eINDs) for Individual patients under 21 CFR 312.310. At the same time, the state of New York announced initiation of a clinical trial using blood plasma ...

On Monday, leaders from ASTCT sent a letter to several members of Congress, urging them to to ensure the implementation of the Defence Production Act (DPA) to manufacture of necessary medical equipment to combat COVID-19. Click here to read more.

The ASTCT Executive Committee has been focused on the impact of COVID-19 on transplantation and cellular therapy patients. We are working with our partner organizations and BMT centers to promote and share information that is critical to our members and their patients... Click here to read more.

The federal government is currently taking a number of measures in response to the COVID-19 pandemic. As of March 13, 2020 the President of the United States issued a proclamation on declaring a national emergency concern on the coronavirus outbreak. The national emergency announcement includes suspension of entry to foreign nationals into the United States who have been in specific jurisdictions where the virus has been prominent. A governmental task force led by VP Mike Pence has been created ...